The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
499 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $737,110,918 in first-year total cost, median $824,998.
Most frequent study sections
- Clinical Neuroscience and Neurodegeneration Study Section[CNN]41
- Special Emphasis Panel[ZRG1 AN-Q (55)]40
- Aging, Injury, Musculoskeletal, and Rheumatologic Disorders Study Section[AIMR]28
- Aging Systems and Geriatrics Study Section[ASG]24
- Special Emphasis Panel[ZRG1 AN-Z (55)]21
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL18
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO17
- BOSTON UNIVERSITY MEDICAL CAMPUS16
- UNIVERSITY OF WISCONSIN-MADISON16
- COLUMBIA UNIVERSITY HEALTH SCIENCES15
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention2RF1NS105479-06 | BENATAR, MICHAELWUU, JOANNE | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $11,282,768 | CNTN |
| 2025 | Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the racially and ethnically diverse SPRINT trial1R01AG096179-01 | BRESS, ADAM PCHHATWAL, JASMEER PPRUZIN, JEREMY JOSEPH | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH, UT | $5,789,766 | CDBA |
| 2025 | Environmental Exposures and Brain Health1RF1AG085457-01A1 | JAMES, PETER | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $5,164,012 | SEDH |
| 2025 | Spatial navigation, sex hormones, and the aging brain1RF1AG096477-01 | CHRASTIL, ELIZABETHJACOBS, EMILY G | UNIVERSITY OF CALIFORNIA SANTA BARBARA, CA | $4,765,698 | HCMF |
| 2025 | Digital speech markers for early detection of Alzheimer’s disease in a longitudinal racially and ethnically diverse cohort1RF1AG091509-01A1 | VONK, JET M.J. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $4,591,694 | CNTN |
| 2025 | Consequences of Exposure to Repetitive Head Impacts Across the Lifespan1RF1NS143015-01 | MCKEE, ANN C. | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $4,269,339 | BIND |
| 2025 | Impact of circulating levels of endocrine disrupting toxicants on cognition, brain activity and Alzheimer's disease biomarkers across the menopausal transition1RF1AG091502-01A1 | EICH, TEAL S | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $4,055,366 | SEDH |
| 2025 | Biological drivers of sex differences in frontotemporal dementia1RF1AG096165-01 | CASALETTO, KAITLIN B | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $3,427,292 | CNTN |
| 2025 | Addressing emotional distress in dyads of persons with a Young Onset Dementia (YOD) and their care-partners1RF1AG096686-01 | DICKERSON, BRADFORD CSYME, MAGGIEVRANCEANU, ANA-MARIA | MASSACHUSETTS GENERAL HOSPITAL, MA | $3,379,666 | ZRG1 |
| 2025 | Small Molecule Ligands Targeting Pathological Tau Signaling In AD And Related Dementias1RF1AG096441-01 | BRADY, SCOTT THOMASTHATCHER, GREGORY R. J | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $3,336,256 | CDIN |
| 2025 | Clarifying the interplay between herpesvirus infection and reactivation, immune responses, APOE genotype, and development of tau-pathology1RF1AG091410-01A1 | BJORNEVIK, KJETIL | HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, MA | $3,280,861 | ZRG1 |
| 2025 | Olfactory dysfunction as predictor of PM2.5 exposure progression to dementia1RF1AG093965-01 | WU, JUNFANGYING, ZHEKANG | UNIVERSITY OF MARYLAND BALTIMORE, MD | $3,264,260 | NAL |
| 2025 | Influence of Interpersonal Connectedness in Spousal Care Dyads on Early Progression of AD1RF1AG096386-01 | CHEN, KUAN-HUA | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $3,240,750 | SPIP |
| 2025 | The Interplay of Neuronal Activity and Synaptic Abnormalities and their Restoration through Mitochondria in Alzheimer's Disease1RF1AG091421-01A1 | SUBRAMANIAN, JAICHANDARYAN, SHIRLEY SHIDU | UNIVERSITY OF KANSAS LAWRENCE, KS | $3,230,150 | NOMD |
| 2025 | Genetic Contributions to Phenotypic Heterogeneity in the ALS-FTD Spectrum1RF1NS145263-01 | MCMILLAN, COREY T | UNIVERSITY OF PENNSYLVANIA, PA | $3,204,260 | CDBA |
| 2025 | Mapping amyloid, tau, and neurodegeneration markers with neuropsychiatric phenotypes and genotypes in Alzheimer's disease continuum using machine learning1RF1AG087271-01A1 | CHAND, GANESH | WASHINGTON UNIVERSITY, MO | $3,188,901 | CDBA |
| 2025 | Functional And Multi-Omics Approaches To Elucidate The Regulation Of Proteasome Complex In Neurodegenerative Diseases1RF1NS143014-01 | MYEKU, NATURA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $3,145,300 | CMND |
| 2025 | The Role of Neighborhood Social Exposome Dynamics in Risk and Resilience to Alzheimer's Disease and Related Dementias1RF1AG091582-01A1 | PETERSON, RACHEL LYNNE | UNIVERSITY OF MONTANA, MT | $3,039,714 | ZRG1 |
| 2025 | Optimizing semantic memory measures of Alzheimer's disease biomarkers1RF1AG093527-01 | GRILLI, MATTHEW D | UNIVERSITY OF ARIZONA, AZ | $3,030,409 | CDBA |
| 2025 | Deciphering the role of CD44 astrocytes in Alzheimer's disease1RF1AG093720-01 | AL DALAHMAH, OSAMA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $2,957,210 | CMBG |
| 2025 | The role of a metazoan-specific PQC system in protecting against TDP-43 proteinopathies1RF1NS145280-01 | YANG, XIAOLU | UNIVERSITY OF PENNSYLVANIA, PA | $2,817,215 | ZRG1 |
| 2025 | Role of TRIM11 in regulating TDP-43 and FUS1RF1NS140530-01A1 | YANG, XIAOLU | UNIVERSITY OF PENNSYLVANIA, PA | $2,709,695 | CMND |
| 2025 | Age-related deficits in episodic memory for the content and structure of naturalistic events1RF1AG085529-01A1 | REAGH, ZACHARIAH MEADOWS | WASHINGTON UNIVERSITY, MO | $2,631,670 | CDBA |
| 2025 | Benefits and Harms of Antihypertensive Management Strategies for Nursing Home Residents with ADRD1RF1AG087210-01A1 | HARRIS, DANIELHAYES, KALEEN NICOLE | UNIVERSITY OF DELAWARE, DE | $2,612,229 | HSQE |
| 2025 | Circuit vulnerability of the lateral and medial entorhinal cortices in tauopathy models of Alzheimer's disease1RF1AG091584-01A1 | IGARASHI, KEI M | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $2,489,452 | CDIN |
| 2025 | Developing a performance-based measure of daily function for screening Hispanic/Latino older adults for Alzheimer's disease risk1RF1AG091339-01A1 | SCHAEFER, SYDNEY YOSHIE | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $2,465,320 | ASG |
| 2025 | Pesticide Use and Markers of ADRD Neurodegeneration among US Farmers1R01AG091698-01 | CHEN, HONGLEIPLASSMAN, BRENDA LRICHARDSON, JASON R | HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI | $2,368,557 | SEDH |
| 2025 | Evaluation of the neuroimmune mechanisms influencing therapeutic targetingpotential of the LH/CG receptor in the menopausal and AD brain1RF1AG091479-01A1 | CASADESUS, GEMMA | UNIVERSITY OF FLORIDA, FL | $2,329,970 | BNRS |
| 2025 | AI-Enhanced and Culturally Adapted STAR-C for Latino Caregivers: A Stage I Pilot Study1RF1AG096360-01 | RAMIREZ, MAGALYYUWEN, WEICHAO | UNIVERSITY OF WASHINGTON, WA | $2,208,923 | ZRG1 |
| 2025 | Unlocking BIN1 function in oligodendrocytes and support of axon integrity1RF1AG091686-01A1 | LI, JIANRONG | TEXAS A&M AGRILIFE RESEARCH, TX | $2,170,748 | CMBG |
| 2025 | The Longitudinal Study of Health and Ageing in Kenya (LOSHAK): A Population study of Health, Wellbeing, Economics, and AD/ADRD in Older Kenyan Adults1R01AG093721-01 | EHRLICH, JOSHUA ROBERTNGUGI, ANTHONY KARANJA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,962,702 | SSPB |
| 2025 | Premenopausal bilateral oophorectomy and biomarkers of Alzheimer’s and cerebrovascular diseases1R01AG093767-01 | KANTARCI, KEJALROCCA, WALTER A | MAYO CLINIC ROCHESTER, MN | $1,775,401 | NMBH |
| 2025 | Clarifying the association of depressive symptoms with cortico-limbic tau, cerebral blood flow, neurodegeneration, and longitudinal cognitive decline in individuals with mild cognitive impairment1R01AG091718-01 | MACKIN, ROBERT SCOTTTOSUN-TURGUT, DUYGU | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,711,908 | ASG |
| 2025 | Tau Conformation in Tauopathies and Neuronal Function2RF1NS082730-11A1 | BRADY, SCOTT THOMASKANAAN, NICHOLAS M | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $1,592,854 | CMND |
| 2025 | Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their Sixties1R01AG091431-01 | YAFFE, KRISTINE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,279,893 | AIMR |
| 2025 | Do auditory tests predict future Alzheimer’s disease pathophysiology1R01AG087264-01A1 | BUCKEY, JAY CROSA-NETO, PEDRO | DARTMOUTH COLLEGE, NH | $1,183,821 | ASG |
| 2025 | ADRD risk and resilience among Black Americans: A 20-year longitudinal study1R01AG087121-01A1 | ANTONUCCI, TONI CLAUDETTEMEZUK, BRIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,059,015 | SSPA |
| 2025 | Characterizing white matter injury in Alzheimer's disease1RF1AG096215-01 | ROYSE, SARAH KOLIBASH | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $1,001,700 | CDBA |
| 2025 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias1R01AG084550-01A1 | FENG, QIPINGWEI, WEI-QI | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $874,857 | ZRG1 |
| 2025 | Microbiome and AD/ADRD Risk in SOL1R01AG085320-01A1 | KAPLAN, ROBERT CPALACIOS, NATALIA | UNIVERSITY OF MASSACHUSETTS LOWELL, MA | $856,580 | AIMR |
| 2025 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD)1R01AG087104-01A1 | MAKHNEVICH, ALEXSINVANI, LIRON DANAY | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $852,049 | CDMA |
| 2025 | First in last out: how development informs neurodegeneration1R01AG093763-01 | GORDON, BRIAN ANDREWWHEELOCK, MURIAH D | WASHINGTON UNIVERSITY, MO | $846,488 | CNTN |
| 2025 | Novel directions for investigating the role of VGF in comorbid Major Depressive Disorder and Alzheimer's disease1R01AG093879-01 | EHRLICH, MICHELLE ESALTON, STEPHEN RWANG, MINGHUI | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $844,931 | CDBA |
| 2025 | Goals of Care Addressing Disparities and Variation for Alzheimer's Disease Nursing Home Care at End of Life1R01AG091541-01A1 | CARPENTER, JOAN GLEBAHANSON, LAURA C | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $843,404 | ICSC |
| 2025 | Exploring NOX2-Mediated Network Impairment and Neurodegeneration in Alzheimer's Disease1R01AG087323-01A1 | ZILBERTER, MISHA YURI | J. DAVID GLADSTONE INSTITUTES, CA | $842,175 | ZRG1 |
| 2025 | CommunityRx-Dementia + Peer Navigation (CRxDpeer): A Real-World Implementation and Effectiveness Study of an IT-Based Social Care Intervention1R01AG091308-01 | HUANG, ELBERT S.LINDAU, STACY TESSLER | UNIVERSITY OF CHICAGO, IL | $819,713 | CMGC |
| 2025 | Cognitive heterogeneity in those with high Alzheimer's Disease Risk2R01AG062109-02A1 | AU, RHODAKOLACHALAMA, VIJAYA B. | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $817,404 | AIMR |
| 2025 | Sex-based contributors to vulnerability to Alzheimer's disease: a multimodal imaging study1R01AG089467-01A1 | FREDERICKS, CAROLYN ANNE | YALE UNIVERSITY, CT | $815,215 | CNTN |
| 2025 | Novel imaging biomarkers of neuroinflammation in Alzheimer's disease1R01AG091760-01 | HARIS, MOHAMMAD | UNIVERSITY OF PENNSYLVANIA, PA | $812,030 | ZRG1 |
| 2025 | Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease2R01AG061800-06 | GAITERI, CHRISTOPHER A.HERSKOWITZ, JEREMY H.SEYFRIED, NICHOLAS THOMAS | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $800,351 | ZRG1 |
| 2025 | Systems Genetics Analysis of Resilience to Tauopathy in ADRD1R01AG085446-01A1 | DUFF, KARENDUNN, AMY | UNIVERSITY COLLEGE LONDON | $799,700 | ZRG1 |
| 2025 | Neuroinflammation, white matter integrity, AD biomarkers and pathology in corticobasal syndrome1R01AG087140-01A1 | JOSEPHS, KEITH AWHITWELL, JENNIFER LOUISE | MAYO CLINIC ROCHESTER, MN | $798,032 | CNN |
| 2025 | Decoding the role of the glycoproteome in Alzheimer’s disease and related disorders.1R01AG091534-01 | BUCHMAN, ARON SKLEIN, HANS-ULRICHSCHNAIDER BEERI, MICHAL | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $795,436 | NMBH |
| 2025 | Blood-brain barrier and microstructural brain biomarkers of ARIA and treatment outcomes with anti-amyloid immunotherapy for Alzheimer's disease1R01AG091503-01 | REAS, EMILIE T. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $794,981 | CNN |
| 2025 | Pathogen-induced cellular senescence and blood-brain barrier dysfunction in Alzheimer's Disease1R01AG091545-01 | REHMAN, JALEES | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $794,341 | ZRG1 |
| 2025 | Autopsy-informed integrated clinical and imaging models for prediction of non-AD co-pathologies in AD1R01AG091657-01 | RANKIN, KATHERINE PTOSUN-TURGUT, DUYGU | NORTHERN CALIFORNIA INSTITUTE/RES/EDU, CA | $791,086 | ZRG1 |
| 2025 | A multidisciplinary study of Alzheimer's disease risk factors in Blacks/African Americans living with HIV1R01AG089864-01A1 | JIANG, XIONG | GEORGETOWN UNIVERSITY, DC | $788,121 | CNTN |
| 2025 | Anatomic, Pathologic, and Molecular Signatures of FTLD-TDP type C1R01AG091388-01 | GEFEN, TAMAR DGEULA, CHANGIZMESULAM, MAREK-MARSEL M | NORTHWESTERN UNIVERSITY, IL | $786,632 | CNN |
| 2025 | Quantifying the Integrity of Sleep-Dependent Memory Processing in Pathological Aging and Alzheimer's Disease: Toward Inexpensive Electroencephalographic Wearable Applications1R01AG087163-01A1 | MCCONNELL, BRICE V | UNIVERSITY OF COLORADO DENVER, CO | $780,466 | MESH |
| 2025 | Urban heat island exposure and its impact on Alzheimer’s disease and related dementia outcomes among older adults in South Florida1R01AG091414-01A1 | BESSER, LILAH | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $777,041 | SEDH |
| 2025 | Flexible multivariate models for linking multi-scale connectome and genome data in Alzheimer’s disease and related disorders1R01AG090597-01 | CALHOUN, VINCE DLIU, JINGYU | GEORGIA STATE UNIVERSITY, GA | $775,475 | ZRG1 |
| 2025 | The impact of stressful and traumatic experiences on the well-being of caregivers and persons living with Alzheimer's disease and related dementias1R01AG091449-01 | BRENES, GRETCHEN AHUGENSCHMIDT, CHRISTINA E | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $774,120 | NMBH |
| 2025 | Neuroimage-genomic fingerprints for subtyping and prediction of Alzheimer's Disease and related dementia1R01AG093792-01 | MA, DA | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $770,558 | CDMA |
| 2025 | Mechanism of ARIA following Anti-Amyloid Immunotherapy1R01AG087397-01A1 | GE, XINURAYAMA, AKIHIKO | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $766,133 | ZRG1 |
| 2025 | Interpretable machine learning methods for the analysis of Alzheimers disease genetics1R01AG089509-01A1 | HE, ZIHUAI | STANFORD UNIVERSITY, CA | $762,636 | ASPA |
| 2025 | Shared Mechanisms of Tau Toxicity Among Neurodegenerative Diseases1R01AG089752-01A1 | LU, BINGWEI | STANFORD UNIVERSITY, CA | $762,144 | NOMD |
| 2025 | Lactate as a regulator of Alzheimer's pathology1R01AG093847-01 | MACAULEY-RAMBACH, SHANNON L | UNIVERSITY OF KENTUCKY, KY | $759,352 | ZRG1 |
| 2025 | Epitranscriptomic Mechanism in pathogenesis of Alzheimer’s disease1R01AG091577-01 | JIANG, LULU | UNIVERSITY OF VIRGINIA, VA | $745,092 | ZRG1 |
| 2025 | Caring for Dementia Caregivers in Ethnic Immigrant Communities1R01AG090561-01A1 | JANG, YURI | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $736,747 | ZRG1 |
| 2025 | Life-space, isolation, and functional exposome study in preclinical Alzheimer's disease and cognitive environments (LIFESPACE)1R01AG089700-01A1 | BABULAL, GANESH M | WASHINGTON UNIVERSITY, MO | $730,089 | CIHB |
| 2025 | Clarifying the overlapping pathology of delirium and dementia2R01AG063849-06 | LENNERTZ, RICHARD CSANDERS, ROBERT D | UNIVERSITY OF WISCONSIN-MADISON, WI | $711,643 | ASG |
| 2025 | Impact of the gut microbiome on B cell-mediated neuroinflammation in cerebral amyloid angiopathy1R01AG085585-01A1 | LEE, JUNEYOUNG | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $696,896 | CNBT |
| 2025 | Activity-dependent astrocyte glucose dynamics regulate hippocampal neurogenesis1R01AG091353-01 | GE, SHAOYUXIONG, QIAOJIE | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $688,419 | NCF |
| 2025 | Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER): Testing the Efficacy of an Intervention to Prevent Psychological Elder Abuse in Family Caregiving1R01AG093797-01 | MEYER, KYLIE NICOLE | CASE WESTERN RESERVE UNIVERSITY, OH | $688,414 | SPIP |
| 2025 | National study of antiepileptic use among patients with dementia in long-term care1R01AG087073-01A1 | GERLACH, LAUREN BETH | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $679,475 | HSQE |
| 2025 | WECARE: A personalized intervention for underserved Chinese American dementia caregivers1R01AG090610-01A1 | HONG, Y. ALICIA | GEORGE MASON UNIVERSITY, VA | $677,026 | ZRG1 |
| 2025 | Analytical Tools for Light-Initiated Zn2+ Signaling in Neurodegenerative Disease1R01AG087372-01A1 | JOHNSON, MICHAEL A. | UNIVERSITY OF KANSAS LAWRENCE, KS | $661,537 | BNVT |
| 2025 | Mediators and Moderators of Executive Function Training in Older Adults1R01AG089508-01A1 | JAEGGI, SUSANNE MSEITZ, AARON R | NORTHEASTERN UNIVERSITY, MA | $655,325 | HCMF |
| 2025 | Endothelial progenitor cells and neurovascular injury in the aging2R01AG064228-07A1 | NATION, DANIEL A | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $649,365 | BIND |
| 2025 | Evaluating clinical and pathological markers of cognitive decline and Alzheimer's dementia in long-duration type 1 diabetes.1R01AG096437-01 | SHAH, HETAL S. | JOSLIN DIABETES CENTER, MA | $645,002 | ASG |
| 2025 | Comparative and Cost-effectiveness of Personalized Targeted Multi-Factorial Approaches to Reducing Disparities in Alzheimer’s Disease and Related Dementias: The TARDIS-AD Project1R56AG089689-01A1 | NIANOGO, ROCH | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $643,139 | NMBH |
| 2025 | Medication self-administration (MSA) and awareness of MSA: life-relevant markers of cognitive impairment1R56AG091682-01A1 | BARRETT, A. M.LIN, HONGHUANGMURABITO, JOANNE M | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $643,089 | ZRG1 |
| 2025 | The Effects of Declining Nursing Home Capacity on Post-Acute and Long-Term Care Access and Health Outcomes among Older Adults and their Caregivers1R01AG096598-01 | MCGARRY, BRIAN | UNIVERSITY OF ROCHESTER, NY | $641,856 | ZRG1 |
| 2025 | Elucidating cerebrovascular disease pathways to cognitive decline with vascular neuroimaging1R01AG089562-01A1 | RIVERA RIVERA, LEONARDO A | UNIVERSITY OF WISCONSIN-MADISON, WI | $640,906 | CNTN |
| 2025 | Missed Home Health Care in Older Adults with Dementia: Identifying Drivers, Outcomes, and Costs1R01AG096563-01 | JONES, CHRISTINE D | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $627,916 | ZRG1 |
| 2025 | Costa Rican Longevity and Healthy Aging Study (CRELES): Wave 41R01AG091512-01 | DOW, WILLIAM H | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $627,212 | SSPA |
| 2025 | Causal and Event Based Modeling of Brain Alterations in ADRD1R01AG087513-01A1 | JAHANSHAD, NEDA | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $622,401 | NMBH |
| 2025 | Effects of Health Shocks at Older Age on Older Adults and their Families: New Evidence from Large-Scale Administrative Data1R56AG096317-01 | POLYAKOVA, MARIA | STANFORD UNIVERSITY, CA | $620,020 | SSPA |
| 2025 | Combinatorial Perturbation with Multi-Omics Readout to Dissect Etiology of Alzheimer's Disease Using Stem Cell and In Vivo Models1R01AG091819-01 | CONG, LE | STANFORD UNIVERSITY, CA | $619,681 | ZRG1 |
| 2025 | Serum protein markers along the Alzheimer's disease trajectory in the population-based longitudinal AGES Reykjavik study and their offsprings2R01AG065596-03 | GUDMUNDSDOTTIR, VALBORG | ICELANDIC HEART ASSOCIATION | $589,171 | AIMR |
| 2025 | Impact of APOE4 on gender-specific mechanism for Alzheimer's disease1R01AG087190-01A1 | KANG, SEONG SU | EMORY UNIVERSITY, GA | $564,530 | ZRG1 |
| 2025 | A macrocyclic peptide platform for the discovery of functional tau epitopes1R01AG091375-01 | DEL VALLE, JUAN R | UNIVERSITY OF NOTRE DAME, IN | $553,998 | CBP |
| 2025 | The role of oral microbially induced exosomes in Alzheimer's disease pathogenesis1R01AG087335-01A1 | ELSAYED, RANYA | AUGUSTA UNIVERSITY, GA | $550,627 | ZRG1 |
| 2025 | Investigating Cis- and Trans-Genetic Regulation of Brain Transcriptomics and Proteomics Associated with AD/ADRD1R01AG089703-01A1 | YANG, JINGJING | EMORY UNIVERSITY, GA | $528,876 | GHD |
| 2025 | Communicating Heath Advancements from Native GEnetics Research (CHANGE Research)1R01AG093837-01 | BOYD, AMANDA D. | WASHINGTON STATE UNIVERSITY, WA | $519,740 | ZRG1 |
| 2025 | Studying roles of CASP8 SVA GGGAGA repeat expansions in Alzheimer's disease1R01AG093746-01 | NGUYEN, LIEN | UNIVERSITY OF FLORIDA, FL | $507,371 | CDIN |
| 2025 | The Role of Reactive Astrocytes in the Propagation and Clearance of Tau in Alzheimer's Disease1R01AG089349-01A1 | SERRANO-POZO, ALBERTO | MASSACHUSETTS GENERAL HOSPITAL, MA | $487,574 | CMBG |
| 2025 | Neurodegenerative reprograming of microglia in Alzheimer’s disease1R01AG085404-01A1 | AYATA, PINAR | ADVANCED SCIENCE RESEARCH CENTER, NY | $442,357 | CMBG |
| 2025 | Enhancing the Implementation, Effectiveness, and Reach of Geriatric Emergency Departments for Older Adults with Dementia (EMERGED)1R01AG089659-01A1 | LIN, MICHELLE P | STANFORD UNIVERSITY, CA | $397,721 | SIHH |
| 2025 | Discovering Heterogeneous Causal Pathophysiology of Alzheimer's Disease1R01AG089512-01A1 | WANG, JINGSHEN | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $372,690 | ASPA |
| 2025 | Cultural variation in the impact of spousal depressive symptoms on Alzheimer's Disease and physical health1R01AG089376-01A1 | CHOPIK, WILLIAM JOSEPH | MICHIGAN STATE UNIVERSITY, MI | $369,654 | SPIP |
| 2025 | Adaptive Testing of Cognitive Function based on multi-dimensional Item Response Theory1R01AG084070-01A1 | GIBBONS, ROBERT D | UNIVERSITY OF CHICAGO, IL | $354,727 | ASPB |
| 2024 | Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions2RF1NS041588-22A1 | CUSHMAN, MARYHOWARD, GEORGEHOWARD, VIRGINIA J.JUDD, SUZANNE EMANLY, JENNIFER JAIE | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $16,244,011 | AIMR |
| 2024 | Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study2R01AG060942-06A1 | LEE, CECILIA SUNGMIN | UNIVERSITY OF WASHINGTON, WA | $7,733,126 | AIMR |
| 2024 | Multi-morbidity 3-City Alzheimer's Disease EHR Study (M3AD Study)1R56AG082167-01A1 | DESVARIEUX, MOISEHRIPCSAK, GEORGE MMAYEUX, RICHARD P | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $5,387,161 | AIMR |
| 2024 | Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis2R01AG061900-11 | BATEMAN, RANDALL J | WASHINGTON UNIVERSITY, MO | $5,175,354 | ZRG1 |
| 2024 | Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)2R01AG058969-06 | HUGHES, TIMOTHY M.LIU, YONGMEILUCHSINGER, JOSE ALEJANDRO | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $4,759,428 | CNN |
| 2024 | Consequences of Incarceration on Health, Age-Related Conditions, and Risk Factors for ADRD1R01AG089544-01 | TEPLIN, LINDA A | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $4,351,542 | CIHB |
| 2024 | P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India1R01AG089759-01 | ALLADI, SUVARNALEVEY, ALLAN IMOHAN, VISWANATHANNARAYAN, KABAYAM M VENKATPRABHAKARAN, DORAIRAJ | EMORY UNIVERSITY, GA | $4,282,638 | AIMR |
| 2024 | Perturbing the LXR/SREBP axis to decipher protective and pathogenic AD/ADRD microglial phenotypes1RF1AG083977-01A1 | COUFAL, NICOLE GABRIELEGLASS, CHRISTOPHER KHOLTZMAN, DAVID M. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $3,840,870 | CMBG |
| 2024 | Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)1R01AG083777-01A1 | JOHNSON-AKEJU, OLUWASEUN | MASSACHUSETTS GENERAL HOSPITAL, MA | $3,506,058 | ASG |
| 2024 | Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II1R01NS139383-01 | ALOSCO, MICHAELRABINOVICI, GIL DANREIMAN, ERIC MICHAELSTERN, ROBERT A | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $3,289,394 | ZRG1 |
| 2024 | Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans1R01AG085571-01A1 | GONZALES, MITZI MICHELLEHABES, MOHAMADTOLEDO ATUCHA, JUAN B | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $2,919,399 | AIMR |
| 2024 | A Proteomic Comparison of Sporadic Early-Onset, Late-Onset, and Autosomal Dominant Alzheimer's Disease1R01AG089497-01 | JOHNSON, ERIK C.B. | EMORY UNIVERSITY, GA | $2,840,883 | ZRG1 |
| 2024 | Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP)1R01AG085689-01A1 | ROSEN, HOWARD J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,724,191 | ZRG1 |
| 2024 | Systems Approaches to Novel Molecular Mechanism in Alzheimer's Disease2RF1AG064909-02 | PENG, JUNMINYU, GANG | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,531,701 | CDIN |
| 2024 | Brain lymphatic activation for craniosynostosis and Alzheimer’s disease1RF1NS137467-01 | CHEN, JIANFU | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $2,461,369 | ZRG1 |
| 2024 | The Microbiome-Gut-Brain Axis and Personalized Mediterranean Diet Interventions for Alzheimer's Dementia Prevention1RF1AG083764-01A1 | CORELLA, DOLORESRUIZ-CANELA, MIGUELSALAS SALVADO, JORDITINAHONES MADUEÑO, FRANCISCO JOSÉWANG, DONG | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,451,933 | KEDD |
| 2024 | PrEDICT ADRD: Predicting the Effects of Diagnosis in Individuals across Countries and Time in ADRD1RF1AG089680-01 | PAPANICOLAS, IRENE N | BROWN UNIVERSITY, RI | $2,393,910 | ZRG1 |
| 2024 | Personal Values in Dementia Experience, Caregiving, and Research1RF1AG083830-01A1 | CHIONG, WINSTON | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,374,537 | ZRG1 |
| 2024 | Telehealth Use in Nursing Homes and the Quality of Care for Long-Stay Residents with Alzheimer's Disease and Related Dementias1RF1AG089362-01 | JUNG, HYE-YOUNGYU, JIANI | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $2,373,964 | ZRG1 |
| 2024 | Impact of change in lifestyle health behaviors on cognition: Harmonizing and leveraging participant-level data from randomized controlled trials1RF1AG089550-01 | HALLOWAY, SHANNON | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $2,366,213 | LCBH |
| 2024 | Usage of Novel Linked Databases to Improve the Perioperative Management of Patients With Alzheimers Disease and Related Dementias1RF1AG085589-01A1 | SUN, ERIC | STANFORD UNIVERSITY, CA | $2,356,117 | ZRG1 |
| 2024 | Imaging of cerebral microvascular pulsatility in cerebral small vessel disease1RF1NS139370-01 | YAN, LIRONG | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,346,270 | ANIE |
| 2024 | Using AI on Routine Clinical and Imaging Data from Acute Stroke Encounter to Predict Post-Stroke Vascular Contributions to Cognitive Impairment (AI - RESPECT)1RF1NS139325-01 | HU, XIAONAHAB, FADI BASILQIU, DEQIANG | EMORY UNIVERSITY, GA | $2,340,263 | CDMA |
| 2024 | Lifetime stressors and Alzheimer's Disease genetic variants and biomarkers in relation to cognitive decline among Black Women'sHealth Study participants.1R01AG082046-01A1 | BARNES, LISA LROSENBERG, LYNN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $2,320,702 | AIMR |
| 2024 | Nextgen AD Models, Endotypes, and Screening1RF1AG084030-01A1 | MUOTRI, ALYSSON R.SUBRAMANIAM, SHANKAR | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $2,319,456 | MNG |
| 2024 | Longitudinal multi-omic biomarkers for neurocognitive decline prior to dementia onset1U01AG083829-01A1 | HARRIS, SARAH ELIZABETH | UNIVERSITY OF EDINBURGH | $2,311,409 | AIMR |
| 2024 | Pulsed laser therapy in an asymptomatic head injury-accelerated Alzheimer's model1RF1NS135548-01A1 | ZHANG, QUANGUANG | AUGUSTA UNIVERSITY, GA | $2,309,898 | BINP |
| 2024 | D-CARE End of Life Study1RF1AG089510-01 | JENNINGS, LEE ALEXANDRA | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $2,303,477 | ZRG1 |
| 2024 | Novel fibril-selective nanobody-based agents targeting intracellular and extracellular α-synuclein aggregates and prion-like propagation induced dementia1RF1NS137428-01 | MAO, XIAOBOWANG, WENJING | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,280,379 | INN |
| 2024 | Advanced Provider Care Models and Health Outcomes of Nursing Home Residents with Dementia1RF1AG085419-01A1 | RYSKINA, KIRA L | UNIVERSITY OF PENNSYLVANIA, PA | $2,278,636 | ZRG1 |
| 2024 | Personality Prediction of Dementia Risk and Progression2RF1AG067622-06A1 | MROCZEK, DANIEL K. | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,274,616 | SPIP |
| 2024 | Prescribing Cascades among Nursing Home Residents with ADRD1RF1AG089541-01 | HAYES, KALEEN NICOLEZULLO, ANDREW REIS | BROWN UNIVERSITY, RI | $2,238,104 | AIMR |
| 2024 | A multimodal examination of functional network health and its relationship with tau deposition1RF1AG085638-01A1 | VISSCHER, KRISTINA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $2,190,943 | ASG |
| 2024 | Resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis1RF1AG085291-01A1 | CHOI, SE HOONHIDE, WINSTON ALEXANDER | MASSACHUSETTS GENERAL HOSPITAL, MA | $2,173,794 | CDIN |
| 2024 | Mathematical modeling of selective vulnerability of genes, cells and network in mouse tauopathy1RF1AG087302-01 | RAJ, ASHISH | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,138,027 | MABS |
| 2024 | Novel Imaging Biomarkers of Lipid and Ketone Metabolism in Alzheimer's Disease1RF1AG087306-01 | REDDY, RAVINDER | UNIVERSITY OF PENNSYLVANIA, PA | $2,105,574 | ZRG1 |
| 2024 | Investigating Pathways from Adverse Pregnancy Outcomes to Alzheimer's Disease and Related Dementias: the nuMoM2b-Brain Study1R01AG085475-01 | MILLER, ELIZA C | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $2,090,311 | RPPH |
| 2024 | Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 11RF1AG085680-01A1 | MASURKAR, ARJUN VIJAY | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,044,038 | CDIN |
| 2024 | Major Histocompatibility Complex I regulation of microglial function in aging and Alzheimer's Disease1RF1AG085573-01A1 | FREEMAN, WILLARD M | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $2,027,220 | CMBG |
| 2024 | Preparing Assisted Living Staff to Care for Persons with Dementia: Palliative Care Education in Assisted Living for Dementia Care Providers1RF1AG087325-01 | DOBBS, DEBRA JEAN | UNIVERSITY OF SOUTH FLORIDA, FL | $1,866,197 | HSQE |
| 2024 | Bio-RaPID: Biomarkers and Rates of Progression In Dementia.1R01AG089380-01 | DAY, GREGORY SCOTT | MAYO CLINIC JACKSONVILLE, FL | $1,794,978 | CNN |
| 2024 | Diagnosis and Risk factors of hippocampal sclerosis of aging and limbic predominant age related TDP-43 encephalopathy; common Alzheimer’s mimics2R01AG062706-06 | SAJJADI, SEYED AHMAD | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $1,775,375 | CNN |
| 2024 | Progressive Post-Stroke Cognitive Impairment: Mechanisms & Intervention2RF1NS104573-07 | ERGUL, ADVIYE | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $1,745,096 | BINP |
| 2024 | Disrupted Lipid Metabolism in Alzheimer's Disease1RF1AG079157-01A1 | YIN, FEI | UNIVERSITY OF ARIZONA, AZ | $1,610,885 | CMBG |
| 2024 | Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimer’s disease and related dementias2R01AG061708-06 | KLEIN, WILLIAM LOZDINLER, PEMBE HANDESILVERMAN, RICHARD B | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $1,536,774 | DMPB |
| 2024 | Validation of the Mayo Test Drive Screening Battery Composite and Stricker Learning Span for Early Detection and Monitoring of Cognitive Decline in Preclinical and Prodromal Alzheimer’s Disease1R01AG081955-01A1 | STRICKER, NIKKI H | MAYO CLINIC ROCHESTER, MN | $1,453,969 | APDA |
| 2024 | REIT Investments in Nursing Homes and the Quality of End of Life Care for Residents with Alzheimer's Disease and Related Dementias1RF1AG082059-01A1 | BRAUN, ROBERT TYLERUNRUH, MARK AARON | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $1,306,862 | ODHS |
| 2024 | Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome1R01AG085572-01 | GINSBERG, STEPHEN DHAVEL, PETER J | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $1,306,289 | ZRG1 |
| 2024 | Construction and Application of Comprehensive Knowledge Graphs for Alzheimer's Disease1R01AG085581-01 | LI, YUNZHU, HONGTU | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,283,911 | ZRG1 |
| 2024 | Environmental Exposome as a Driver of Race/Ethnicity Differences in Alzheimer's Disease1R01AG085279-01A1 | GERMAN, DWIGHT C.JONES, DEAN PAULRICHARDSON, JASON R | UT SOUTHWESTERN MEDICAL CENTER, TX | $1,205,827 | SEDH |
| 2024 | Social epigenetics of Alzheimer's disease and related dementias in Latin American countries1R01AG082056-01A1 | CORLEY, MICHAEL JAYIBANEZ, AGUSTIN M.SANTAMARIA-GARCIA, HERNANDO | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $1,199,134 | NMBH |
| 2024 | The Neuropathologic Landscape of Alzheimer's Disease in Hispanic Decedents2R01AG062517-06A1 | DUGGER, BRITTANY NICOLE | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $1,149,318 | CNN |
| 2024 | Optimism and Dementia-Related Health Outcomes1R01AG085375-01A1 | GRODSTEIN, FRANCINEKUBZANSKY, LAURA D | HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, MA | $1,119,766 | NMBH |
| 2024 | IL-6 Trans-signaling increases vulnerability to Postoperative Cognitive Decline in Aging and Alzheimers Disease1R01AG083979-01A1 | MAZE, MERVYNTERRANDO, NICCOLO | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,117,062 | ZRG1 |
| 2024 | Informal Caregiving Networks of Older Adults with Dementia1R01AG082300-01A1 | SONG, MI-KYUNG | EMORY UNIVERSITY, GA | $1,030,776 | SPIP |
| 2024 | Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies1R01NS137469-01 | CRACCO, LAURANEWELL, KATHY LRYSKELDI-FALCON, BENJAMIN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $1,029,657 | ZRG1 |
| 2024 | Mechanistic links between the benefits of pharmacologically high thiamine (vitamin B1) in Alzheimer's disease to Advanced Glycation Endproducts (AGE)1R01AG082228-01A1 | FLOWERS, SARAH ANNGIBSON, GARY EZHANG, SHENG | WINIFRED MASTERSON BURKE MED RES INST, NY | $1,018,953 | ZRG1 |
| 2024 | Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease1R01AG085557-01A1 | GOLDE, TODD ELEVITES, YONA RROWAN, MATTHEW J.M. | EMORY UNIVERSITY, GA | $1,010,081 | CNBT |
| 2024 | Improving Inclusivity of Alzheimer’s Disease and Related Dementias Research for Asian Americans and Latinx through Nationally Representative Hybrid Sampling.1R01AG082080-01A1 | LEE, SUNG-HEE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $979,196 | ASPB |
| 2024 | Country, cohort, and gender disparities in the relationship between education and ADRD1R01AG081248-01A1 | FINCH, BRIAN K.FINKEL, DEBORAH GGATZ, MARGARET | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $961,455 | SSPB |
| 2024 | Study Alzheimer's Disease Protective APOE Variants1R01AG085468-01 | HUANG, YADONGZILBERTER, MISHA YURI | J. DAVID GLADSTONE INSTITUTES, CA | $941,364 | ZRG1 |
| 2024 | Mechanisms of Somatic Mutation in Alzheimer's Disease Using Single Neuron Analysis1R01AG082346-01A1 | MILLER, MICHAEL B | BRIGHAM AND WOMEN'S HOSPITAL, MA | $913,297 | MNG |
| 2024 | Wake-sleep Circuitry in Neurodegenerative Dementias1R01AG082016-01A1 | SAPER, CLIFFORD B | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $900,121 | CNN |
| 2024 | Identification of brain metabolomic profiles associated with dementia1R01AG087356-01 | LI, JUN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $897,661 | ASG |
| 2024 | Vitamin D and Gut Microbiota and Dementia Risk in Older Adults with Chronic HIV infection and Demographically Matched Community Controls1R01AG087191-01 | EZEAMAMA, AMARA EGIORDANI, BRUNO | HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES, MI | $887,772 | ASG |
| 2024 | Blood-based Alzheimer's biomarker detection at the point of care1R56AG087357-01 | SHAFIEE, HADI | BRIGHAM AND WOMEN'S HOSPITAL, MA | $885,006 | EBIT |
| 2024 | Understanding Ambulatory Care Utilization in Alzheimer's Disease and Related Dementias (ACUA)1R01AG087243-01 | KERN, LISA M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $879,502 | HSQE |
| 2024 | Big data and small molecules for Alzheimer's disease2R01AG063913-02 | XIA, WEIMING | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $870,242 | ZRG1 |
| 2024 | Novel Neuroprotective Roles for the Alzheimer's Disease Risk Gene SORLA in Tau Pathology and Pathogenesis1R01AG085498-01 | HUANG, TIMOTHY YIKAI | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $867,695 | CMND |
| 2024 | Ahead of the Curve: Early detection and monitoring of learning decrements in Alzheimers disease1R01AG084017-01A1 | PAPP, KATHRYN VICTORIA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $867,107 | CNN |
| 2024 | Telehealth Use and the Quality of End-of-Life Care for Nursing Home Residents with Alzheimer's Disease and Alzheimer's Disease-Related Dementias1R01AG089702-01 | YU, JIANI | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $858,870 | ZRG1 |
| 2024 | Atypical astrocytes in aging and Alzheimer's Disease1R01AG085666-01 | DULLA, CHRIS G | TUFTS UNIVERSITY BOSTON, MA | $854,851 | CMBG |
| 2024 | Role of EphA1/A2 domain-domain and -membrane interactions for receptor specificity and Blood Brain Barrier dysfunction1R01AG089561-01 | BUCK, MATTHIAS | CASE WESTERN RESERVE UNIVERSITY, OH | $852,309 | MSFC |
| 2024 | Characterization of AD-related endolysosomal dysfunction in human neural cells1R01AG080585-01A1 | JAYADEV, SUMANYOUNG, JESSICA ELAINE | UNIVERSITY OF WASHINGTON, WA | $851,663 | CMND |
| 2024 | Illuminating our understanding of statins and Alzheimers Disease and Dementia using modern causal inference methods1R01AG081973-01A1 | CALONICO, NESTOR SEBASTIANODDEN, MICHELLE CHRISTINAZEKI AL HAZZOURI, ADINA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $839,767 | NMBH |
| 2024 | Transcriptomics-based identification of cell type specific host genes and gene networks perturbed by HSV-1 in cerebral organoids.1R01AG083881-01A1 | LIM, TENG-TING ELAINE | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $837,492 | MNG |
| 2024 | Hypertension, Blood Pressure Targets, and Alzheimer’s Disease and Dementia Risk and Disparities among Nationally Representative US Veterans1R01AG085481-01 | CALONICO, NESTOR SEBASTIANYAFFE, KRISTINEZEKI AL HAZZOURI, ADINA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $836,669 | ASG |
| 2024 | Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related Dementias1R01AG083735-01A1 | AU, RHODAKOLACHALAMA, VIJAYA B.LIN, HONGHUANG | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $835,868 | AIMR |
| 2024 | The cross-talk between a-Synucleinopathies and T cell immunity in ADRD1R01AG089605-01 | MAO, XIAOBOPENG, WEIYI | JOHNS HOPKINS UNIVERSITY, MD | $834,685 | ZRG1 |
| 2024 | ERAD-STING Crosstalk in Microglia: Unraveling the Pathogenesis of Alzheimer's Disease1R01AG089640-01 | QI, LINGZHAO, ZHEN | UNIVERSITY OF VIRGINIA, VA | $831,872 | ZRG1 |
| 2024 | Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology1R01AG085643-01 | ANDREANO, JOSEPH MDICKERSON, BRADFORD C | MASSACHUSETTS GENERAL HOSPITAL, MA | $830,324 | APDA |
| 2024 | Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin1R01AG089711-01 | ESPINOZA, SARA ELYSEGONZALES, MITZI MICHELLEMUSI, NICOLAS | CEDARS-SINAI MEDICAL CENTER, CA | $828,960 | ZRG1 |
| 2024 | Neuroimmune Genomic Profiling of Alzheimer's Disease1U01AG085679-01 | ROGAEV, EVGENY I | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $828,534 | ZRG1 |
| 2024 | Development of sensitive PET tracers of pan-Amyloid-beta species for Alzheimer's disease1R01AG085562-01 | RAN, CHONGZHAO | MASSACHUSETTS GENERAL HOSPITAL, MA | $826,732 | ZRG1 |
| 2024 | Gut microbiome-related metabolites and cognitive impairment1R01AG089361-01 | KIMBERLY, WILLIAM TAYLOR | MASSACHUSETTS GENERAL HOSPITAL, MA | $825,135 | AIMR |
| 2024 | Environmental Resources for Individual Cognitive Health/Resilience (EnRICH)1R01AG087199-01 | PESCADOR JIMENEZ, MARCIA IXCHEL | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $824,386 | SEDH |
| 2024 | Molecular Chemiluminescence Probes for Imaging of Amyloid beta in Animal Models1R01AG083759-01A1 | RAN, CHONGZHAOZHANG, CAN MARTIN | MASSACHUSETTS GENERAL HOSPITAL, MA | $823,551 | IPCA |
| 2024 | Building Primary Care Workforce Capacity in the Dementia Diagnostic Process1R01AG087166-01 | SIDEMAN, ALISSA BERNSTEIN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $821,286 | ZRG1 |
| 2024 | Chemical Approaches to Understand O-GlcNAc Glycosylation and Its Roles in Neurodegeneration2R01AG060540-14 | HSIEH-WILSON, LINDA C | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $821,056 | CBP |
| 2024 | Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression1R01AG089717-01 | LI, BINGSHANWEN, ZHEXING | VANDERBILT UNIVERSITY, TN | $820,536 | ZRG1 |
| 2024 | Elucidating the Link Between Oral Health and Dementia Subtypes: A Multifaceted Study on the Biological Pathways and Social Determinants1R01AG089856-01 | LUO, HUABINWU, BEI | NEW YORK UNIVERSITY, NY | $819,054 | AIMR |
| 2024 | MIF Nuclease actions in Synuclein Dementias1R01AG085688-01 | DAWSON, TED M.DAWSON, VALINA L. | JOHNS HOPKINS UNIVERSITY, MD | $818,421 | ZRG1 |
| 2024 | Long-term care integration for dually eligible individuals with Alzheimer's disease and related dementias1R01AG083756-01A1 | KIM, HYUNJEE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $811,083 | ZRG1 |
| 2024 | Social Networks in Nurse Practitioner Teams Caring for Patients with Dementia and Impact on Racial and Ethnic Disparities1R01AG085479-01 | POGHOSYAN, LUSINE | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $810,548 | ODHS |
| 2024 | Air pollution, the blood and brain metabolome and their effects on Alzheimer's disease and related dementias1R01AG087250-01 | HUELS, ANKELIANG, DONGHAI | EMORY UNIVERSITY, GA | $807,966 | AIMR |
| 2024 | Improving hospice care for racial and ethnic minoritized older adults with Alzheimer’s Disease and Related Dementias (ADRD)1R01AG085347-01 | HARRISON, KRISTA LYN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $806,723 | ODHS |
| 2024 | Pathology-guided biofluid biomarker strategies for classification and progression of frontotemporal lobar degeneration (FTLD)1R01AG087258-01 | COUSINS, KATHERYN ALEXANDRA QUILICO | UNIVERSITY OF PENNSYLVANIA, PA | $805,790 | CNN |
| 2024 | The impact of brain lipoprotein structure and composition on amyloid beta metabolism and Alzheimer's disease1R01NS125591-01A1 | MELCHIOR, JOHN | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | $805,738 | MSFB |
Showing the 200 most recent of 499 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.